Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced its management team will present at the UBS Global Healthcare Conference on May 25, 2022, at 1:15 p.m. ET in New York. The presentation will focus on Inspire's innovative, minimally invasive solutions for obstructive sleep apnea, including its FDA-approved neurostimulation technology, Inspire therapy. A live webcast will be available for those unable to attend in person, with a replay accessible for two weeks post-event on Inspire’s investor website.

MINNEAPOLIS, May 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the UBS Global Healthcare Conference on May 25, 2022 at the Lotte New York Palace in New York, New York.

Inspire is scheduled to present at 1:15 p.m. Eastern Time. The presentation will be accessible via a live webcast at https://kvgo.com/ubs-global-healthcare-2022/inspire-medical-systems-may

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989

FAQ

What date will Inspire Medical Systems present at the UBS Global Healthcare Conference?

Inspire Medical Systems will present on May 25, 2022.

What time is Inspire Medical Systems' presentation at the UBS Conference?

The presentation is scheduled for 1:15 p.m. Eastern Time.

How can I access Inspire Medical Systems' presentation at the UBS Conference?

The presentation will be accessible via a live webcast at Inspire's website.

Will there be a replay of Inspire Medical Systems' presentation available?

Yes, a replay will be available for two weeks after the presentation.

What is Inspire therapy and its significance?

Inspire therapy is the first and only FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.